Related Experiment Video
Updated: Feb 19, 2026

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Distal Hereditary Motor Neuropathy Type II (Distal HMN Type II): Phenotype and Molecular Genetics
V Timmerman1, J Beuten1, J Irobi1
1Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology (VIB) and Laboratory of Neurogenetics, Born-Bunge Foundation (BBS), University of Antwerpen (UIA), Department of Biochemistry, Universiteitsplein 1, Antwerpen, BelgiumDivision of Neurology, University Hospital Antwerpen (UZA), Antwerpen, BelgiumLaboratory of Neuropathology, BornBunge Foundation (BBS), University of Antwerpen (UIA), Department of Medicine, Antwerpen, Belgium.
Researchers identified a new gene locus for distal hereditary motor neuropathy type II on chromosome 12q24.3 in a Belgian family. Further studies are ongoing to pinpoint the specific gene responsible for this rare neurological disorder.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Distal hereditary motor neuropathies (distal HMN) are a group of rare, inherited neurological disorders characterized by progressive muscle weakness and sensory loss, primarily affecting the distal extremities.
- These neuropathies exhibit significant clinical and genetic heterogeneity, necessitating detailed genetic mapping to identify causative genes.
- Autosomal dominant distal HMN type II presents with a phenotype similar to Charcot-Marie-Tooth disease, with onset typically between 15 and 25 years.
Purpose of the Study:
- To identify the genetic basis of autosomal dominant distal HMN type II in a multigenerational Belgian pedigree.
- To investigate the chromosomal location of the responsible gene and explore potential candidate genes.
Main Methods:
- Genome-wide linkage analysis was performed on affected family members.
- Microsatellite markers, including D12S86 and D12S340, were used to narrow down the chromosomal region.
- Positional candidate gene screening, including the human pancreatic phospholipase A2 (PLA2A) gene, was conducted.
Main Results:
- Significant linkage was established to chromosome 12q24.3, specifically between markers D12S86 and D12S340.
- The human pancreatic phospholipase A2 (PLA2A) gene was identified as a positional candidate but initial screening did not reveal disease-causing mutations in its coding region.
- A yeast artificial chromosome (YAC) contig map of the candidate region was constructed to facilitate gene isolation.
Conclusions:
- A novel locus for distal HMN type II has been mapped to chromosome 12q24.3.
- The gene responsible for distal HMN II in this family is likely located within this region, but PLA2A is not the causative gene.
- Ongoing screening of positional and functional candidate genes is crucial for identifying the specific mutation responsible for distal HMN II.
Related Concept Videos
Incomplete Dominance
Pedigree Analysis
Genetic Lingo
Pleiotropy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Principles of Pharmacogenetics: Types of Genetic Variants

